ACLARIS THERAPEUTICS Trademark

Trademark Overview

On Monday, April 2, 2018, a trademark application was filed for ACLARIS THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ACLARIS THERAPEUTICS trademark a serial number of 87858709. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 7, 2020. This trademark is owned by Aclaris Therapeutics, Inc.. The ACLARIS THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of pharmaceutical preparations, products and technology in the fields of dermatology; providing medical and scientific research information in the fields of dermatology, pharmaceuticals and clinical trials; drug discovery services
aclaris therapeutics

General Information

Serial Number87858709
Word MarkACLARIS THERAPEUTICS
Filing DateMonday, April 2, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 7, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 12, 2018

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"THERAPEUTICS"
Description of MarkThe mark consists of capital letters "ACLARIS" centered over smaller capital letters "THERAPEUTICS", which are placed over on the right side of a partial circle design comprised of five segmented curved lines.
Goods and ServicesResearch and development of pharmaceutical preparations, products and technology in the fields of dermatology; providing medical and scientific research information in the fields of dermatology, pharmaceuticals and clinical trials; drug discovery services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 9, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAclaris Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWayne, PA 19087
Party NameAclaris Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMalvern, PA 19355

Trademark Events

Event DateEvent Description
Tuesday, September 8, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 7, 2020ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 5, 2020REVIEW OF CORRESPONDENCE COMPLETE
Monday, June 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 1, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, June 1, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 1, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 5, 2020EXTENSION 3 GRANTED
Wednesday, February 5, 2020EXTENSION 3 FILED
Wednesday, February 5, 2020TEAS EXTENSION RECEIVED
Thursday, August 1, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 30, 2019EXTENSION 2 GRANTED
Tuesday, July 30, 2019EXTENSION 2 FILED
Tuesday, July 30, 2019TEAS EXTENSION RECEIVED
Friday, January 25, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 23, 2019EXTENSION 1 GRANTED
Wednesday, January 23, 2019EXTENSION 1 FILED
Wednesday, January 23, 2019TEAS EXTENSION RECEIVED
Tuesday, December 4, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 4, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 16, 2018CORRECTED NOA E-MAILED
Thursday, November 15, 2018DIVISIONAL PROCESSING COMPLETE
Tuesday, November 13, 2018DIVISIONAL REQUEST RECEIVED
Tuesday, November 13, 2018TEAS REQUEST TO DIVIDE RECEIVED
Friday, October 5, 2018REQUEST TO DIVIDE UNTIMELY, REFUSED, OR WITHDRAWN
Wednesday, September 19, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 13, 2018TEAS REQUEST TO DIVIDE RECEIVED
Thursday, August 30, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 30, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 7, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 12, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 12, 2018PUBLISHED FOR OPPOSITION
Wednesday, May 23, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 10, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 9, 2018ASSIGNED TO LIE
Friday, April 27, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 27, 2018EXAMINER'S AMENDMENT ENTERED
Friday, April 27, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, April 27, 2018EXAMINERS AMENDMENT E-MAILED
Friday, April 27, 2018EXAMINERS AMENDMENT -WRITTEN
Tuesday, April 24, 2018ASSIGNED TO EXAMINER
Friday, April 13, 2018TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Friday, April 13, 2018TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, April 10, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, April 9, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, April 5, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

therapeutics aclaris fields dermatology research pharmaceuticals clinical trials services discovery drug information